The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Alzheimer’s Disease Diagnostic Market Research Report 2025

Global Alzheimer’s Disease Diagnostic Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1416830

No of Pages : 164

Ask Your Query

Synopsis

The diagnosis of alzheimer's disease is divided into three steps. The first step is to determine whether it is alzheimer's disease.The second step is to look for the cause, to look for biomarkers such as prolapidin-1, prolapidin-2 and the amyloid gene, amyloid deposition, or hippocampal volume or medial temporal lobe volume atrophy, and the apolipoprotein E4 allele.The third step is to determine the extent of the disease, which can be determined by a simple mental state examination or the patient's response.

The global Alzheimer’s Disease Diagnostic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Alzheimer’s Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer’s Disease Diagnostic.

Report Scope

The Alzheimer’s Disease Diagnostic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Alzheimer’s Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Alzheimer’s Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Eli Lilly and Company
  • Novartis
  • Merck
  • F. Hoffmann-La Roche
  • Pfizer
  • TauRx
  • Alector
  • Accera
  • Treventis Corporation
  • Neuro-Bio
  • Cognition Therapeutics

Segment by Type

  • Nervous System Examination
  • Genetic Testing
  • Minor Mental State Examination (Mmse)
  • Brain Imaging

Segment by Application

  • Early-Onset Alzheimer's Disease
  • Familial Alzheimer's Disease
  • Late-Onset Alzheimer's Disease

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer’s Disease Diagnostic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Nervous System Examination
1.2.3 Genetic Testing
1.2.4 Minor Mental State Examination (Mmse)
1.2.5 Brain Imaging
1.3 Market by Application
1.3.1 Global Alzheimer’s Disease Diagnostic Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Early-Onset Alzheimer's Disease
1.3.3 Familial Alzheimer's Disease
1.3.4 Late-Onset Alzheimer's Disease
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer’s Disease Diagnostic Market Perspective (2019-2030)
2.2 Alzheimer’s Disease Diagnostic Growth Trends by Region
2.2.1 Global Alzheimer’s Disease Diagnostic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Alzheimer’s Disease Diagnostic Historic Market Size by Region (2019-2024)
2.2.3 Alzheimer’s Disease Diagnostic Forecasted Market Size by Region (2025-2030)
2.3 Alzheimer’s Disease Diagnostic Market Dynamics
2.3.1 Alzheimer’s Disease Diagnostic Industry Trends
2.3.2 Alzheimer’s Disease Diagnostic Market Drivers
2.3.3 Alzheimer’s Disease Diagnostic Market Challenges
2.3.4 Alzheimer’s Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue
3.1.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue (2019-2024)
3.1.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Players (2019-2024)
3.2 Global Alzheimer’s Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Alzheimer’s Disease Diagnostic Revenue
3.4 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio
3.4.1 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Diagnostic Revenue in 2023
3.5 Alzheimer’s Disease Diagnostic Key Players Head office and Area Served
3.6 Key Players Alzheimer’s Disease Diagnostic Product Solution and Service
3.7 Date of Enter into Alzheimer’s Disease Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer’s Disease Diagnostic Breakdown Data by Type
4.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Type (2019-2024)
4.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2025-2030)
5 Alzheimer’s Disease Diagnostic Breakdown Data by Application
5.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Application (2019-2024)
5.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Alzheimer’s Disease Diagnostic Market Size (2019-2030)
6.2 North America Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Alzheimer’s Disease Diagnostic Market Size by Country (2019-2024)
6.4 North America Alzheimer’s Disease Diagnostic Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer’s Disease Diagnostic Market Size (2019-2030)
7.2 Europe Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Alzheimer’s Disease Diagnostic Market Size by Country (2019-2024)
7.4 Europe Alzheimer’s Disease Diagnostic Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size (2019-2030)
8.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2019-2024)
8.4 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer’s Disease Diagnostic Market Size (2019-2030)
9.2 Latin America Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2019-2024)
9.4 Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size (2019-2030)
10.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2019-2024)
10.4 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Detail
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Introduction
11.1.4 Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.1.5 Eli Lilly and Company Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Alzheimer’s Disease Diagnostic Introduction
11.2.4 Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Alzheimer’s Disease Diagnostic Introduction
11.3.4 Merck Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.3.5 Merck Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Detail
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Alzheimer’s Disease Diagnostic Introduction
11.5.4 Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 TauRx
11.6.1 TauRx Company Detail
11.6.2 TauRx Business Overview
11.6.3 TauRx Alzheimer’s Disease Diagnostic Introduction
11.6.4 TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.6.5 TauRx Recent Development
11.7 Alector
11.7.1 Alector Company Detail
11.7.2 Alector Business Overview
11.7.3 Alector Alzheimer’s Disease Diagnostic Introduction
11.7.4 Alector Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.7.5 Alector Recent Development
11.8 Accera
11.8.1 Accera Company Detail
11.8.2 Accera Business Overview
11.8.3 Accera Alzheimer’s Disease Diagnostic Introduction
11.8.4 Accera Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.8.5 Accera Recent Development
11.9 Treventis Corporation
11.9.1 Treventis Corporation Company Detail
11.9.2 Treventis Corporation Business Overview
11.9.3 Treventis Corporation Alzheimer’s Disease Diagnostic Introduction
11.9.4 Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.9.5 Treventis Corporation Recent Development
11.10 Neuro-Bio
11.10.1 Neuro-Bio Company Detail
11.10.2 Neuro-Bio Business Overview
11.10.3 Neuro-Bio Alzheimer’s Disease Diagnostic Introduction
11.10.4 Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.10.5 Neuro-Bio Recent Development
11.11 Cognition Therapeutics
11.11.1 Cognition Therapeutics Company Detail
11.11.2 Cognition Therapeutics Business Overview
11.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Introduction
11.11.4 Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024)
11.11.5 Cognition Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Nervous System Examination
Table 3. Key Players of Genetic Testing
Table 4. Key Players of Minor Mental State Examination (Mmse)
Table 5. Key Players of Brain Imaging
Table 6. Global Alzheimer’s Disease Diagnostic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Alzheimer’s Disease Diagnostic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Alzheimer’s Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Alzheimer’s Disease Diagnostic Market Share by Region (2019-2024)
Table 10. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Alzheimer’s Disease Diagnostic Market Share by Region (2025-2030)
Table 12. Alzheimer’s Disease Diagnostic Market Trends
Table 13. Alzheimer’s Disease Diagnostic Market Drivers
Table 14. Alzheimer’s Disease Diagnostic Market Challenges
Table 15. Alzheimer’s Disease Diagnostic Market Restraints
Table 16. Global Alzheimer’s Disease Diagnostic Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Alzheimer’s Disease Diagnostic Market Share by Players (2019-2024)
Table 18. Global Top Alzheimer’s Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2023)
Table 19. Ranking of Global Top Alzheimer’s Disease Diagnostic Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Alzheimer’s Disease Diagnostic Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Alzheimer’s Disease Diagnostic Product Solution and Service
Table 23. Date of Enter into Alzheimer’s Disease Diagnostic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer’s Disease Diagnostic Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2019-2024)
Table 27. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2025-2030)
Table 29. Global Alzheimer’s Disease Diagnostic Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2019-2024)
Table 31. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2025-2030)
Table 33. North America Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Alzheimer’s Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Alzheimer’s Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2025-2030) & (US$ Million)
Table 48. Eli Lilly and Company Company Detail
Table 49. Eli Lilly and Company Business Overview
Table 50. Eli Lilly and Company Alzheimer’s Disease Diagnostic Product
Table 51. Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 52. Eli Lilly and Company Recent Development
Table 53. Novartis Company Detail
Table 54. Novartis Business Overview
Table 55. Novartis Alzheimer’s Disease Diagnostic Product
Table 56. Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. Merck Company Detail
Table 59. Merck Business Overview
Table 60. Merck Alzheimer’s Disease Diagnostic Product
Table 61. Merck Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 62. Merck Recent Development
Table 63. F. Hoffmann-La Roche Company Detail
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product
Table 66. F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. Pfizer Company Detail
Table 69. Pfizer Business Overview
Table 70. Pfizer Alzheimer’s Disease Diagnostic Product
Table 71. Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. TauRx Company Detail
Table 74. TauRx Business Overview
Table 75. TauRx Alzheimer’s Disease Diagnostic Product
Table 76. TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 77. TauRx Recent Development
Table 78. Alector Company Detail
Table 79. Alector Business Overview
Table 80. Alector Alzheimer’s Disease Diagnostic Product
Table 81. Alector Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 82. Alector Recent Development
Table 83. Accera Company Detail
Table 84. Accera Business Overview
Table 85. Accera Alzheimer’s Disease Diagnostic Product
Table 86. Accera Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 87. Accera Recent Development
Table 88. Treventis Corporation Company Detail
Table 89. Treventis Corporation Business Overview
Table 90. Treventis Corporation Alzheimer’s Disease Diagnostic Product
Table 91. Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 92. Treventis Corporation Recent Development
Table 93. Neuro-Bio Company Detail
Table 94. Neuro-Bio Business Overview
Table 95. Neuro-Bio Alzheimer’s Disease Diagnostic Product
Table 96. Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 97. Neuro-Bio Recent Development
Table 98. Cognition Therapeutics Company Detail
Table 99. Cognition Therapeutics Business Overview
Table 100. Cognition Therapeutics Alzheimer’s Disease Diagnostic Product
Table 101. Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2019-2024) & (US$ Million)
Table 102. Cognition Therapeutics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Alzheimer’s Disease Diagnostic Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Alzheimer’s Disease Diagnostic Market Share by Type: 2023 VS 2030
Figure 3. Nervous System Examination Features
Figure 4. Genetic Testing Features
Figure 5. Minor Mental State Examination (Mmse) Features
Figure 6. Brain Imaging Features
Figure 7. Global Alzheimer’s Disease Diagnostic Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Alzheimer’s Disease Diagnostic Market Share by Application: 2023 VS 2030
Figure 9. Early-Onset Alzheimer's Disease Case Studies
Figure 10. Familial Alzheimer's Disease Case Studies
Figure 11. Late-Onset Alzheimer's Disease Case Studies
Figure 12. Alzheimer’s Disease Diagnostic Report Years Considered
Figure 13. Global Alzheimer’s Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Alzheimer’s Disease Diagnostic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Alzheimer’s Disease Diagnostic Market Share by Region: 2023 VS 2030
Figure 16. Global Alzheimer’s Disease Diagnostic Market Share by Players in 2023
Figure 17. Global Top Alzheimer’s Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Alzheimer’s Disease Diagnostic Revenue in 2023
Figure 19. North America Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Alzheimer’s Disease Diagnostic Market Share by Country (2019-2030)
Figure 21. United States Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Alzheimer’s Disease Diagnostic Market Share by Country (2019-2030)
Figure 25. Germany Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Alzheimer’s Disease Diagnostic Market Share by Region (2019-2030)
Figure 33. China Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Alzheimer’s Disease Diagnostic Market Share by Country (2019-2030)
Figure 41. Mexico Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Alzheimer’s Disease Diagnostic Market Share by Country (2019-2030)
Figure 45. Turkey Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Eli Lilly and Company Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 48. Novartis Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 49. Merck Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 50. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 52. TauRx Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 53. Alector Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 54. Accera Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 55. Treventis Corporation Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 56. Neuro-Bio Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 57. Cognition Therapeutics Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock